The consultant had deleted records involving McKinsey’s role in pushing OxyContin sales and driving the opioid crisis.
Related Posts
Florida IV Plant Spared From Storm, Company Says
Milton threatened a Daytona Beach site that produces one-fourth of the nation’s IV medical solutions, which were already in short…
Upended by Meth, Some Communities Are Paying Users to Quit
Unlike with opioids, there is no medication to suppress cravings for meth and other stimulants. As use soars, hundreds of…
Help The Times Report on Optum-Controlled Doctor’s Offices
The Times wants to hear from patients and providers about medical practices affiliated with Optum, a subsidiary of UnitedHealth Group.…